Clinical Trials Logo

Clinical Trial Summary

A clinical study to test the effectiveness of an investigational drug to treat people that have major depressive episodes when they have Bipolar 1 Depression


Clinical Trial Description

This is a randomized, double-blind, placebo-controlled, parallel-group, fixed-dose study designed to evaluate the efficacy, safety, and tolerability of treatment with SEP-4199 monotherapy given as 200 mg/day or 400 mg/day compared with placebo for the treatment of major depressive episodes associated with bipolar I disorder (bipolar I depression). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03543410
Study type Interventional
Source Sunovion
Contact
Status Completed
Phase Phase 2
Start date June 26, 2018
Completion date April 23, 2020

See also
  Status Clinical Trial Phase
Completed NCT04469322 - Pharmacogenetic Implementation Trial in Veterans With Treatment Refractory Depression N/A
Recruiting NCT02481245 - BezafibrateTreatment for Bipolar Depression: A Proof of Concept Study Phase 2
Completed NCT03449979 - Single Session of tACS in a Depressive Episode N/A
Recruiting NCT05708222 - Sleep Signal Analysis for Current Major Depressive Episode (SAMDE)
Completed NCT01879111 - Increasing the Efficiency of Depression-screening Using Patient-targeted Feedback N/A
Unknown status NCT01212848 - Transcranial Magnetic Stimulation (TMS) for Suicidal Ideation Phase 3
Not yet recruiting NCT05547711 - Prediction and Validation of Unipolar Depression With Psychosocial-somatic Markers in a Naturalistic Cohort Recruited in an Outpatient Setting N/A
Completed NCT04239521 - The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata
Completed NCT03288714 - Adaptive Design Study of NEST sTMS in Subjects With Major Depressive Disorder N/A
Completed NCT03899168 - Confirmation Bias Towards Treatments of Depressive Disorders in Social Tagging N/A
Terminated NCT03537547 - Combinatorial Pharmacogenomics Testing in Treatment-Naïve Major Depressive Disorder Phase 4
Terminated NCT04383509 - Electroconvulsive Treatment Followed by Cognitive Control Training N/A
Completed NCT05683028 - RCT for Electroconvulsive Treatment Followed by Cognitive Control Training N/A
Enrolling by invitation NCT05701345 - Study of Virtual Reality-based Medical Device for Patients With Depressive Disorder N/A
Recruiting NCT04123301 - Theta-Burst Stimulation in Major Depressive Episodes With Mixed Characteristics. N/A
Completed NCT05686408 - Study to Evaluate TNX-601 ER Monotherapy Versus Placebo in Patients With Major Depressive Disorder (MDD) Phase 2
Completed NCT04953338 - Mental Health Associations With Vitiligo
Completed NCT05462652 - Self-guided Treatment for Adolescents Navigating Depression N/A
Recruiting NCT03944213 - Resting-state Functional Connectivity Throughout a Course of iTBS in Major Depression
Not yet recruiting NCT04658420 - A Single Ketamine Infusion Combined With Music for Suicidal Ideation Phase 2